Tradewinds Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Tradewinds Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-13	Closed	-$1K	–	725
2016 Q3	$1K	Buy	+13	New	+$1.04K	﹤0.01%	636
2016 Q1	–	Sell	-2	Closed	–	–	710
2015 Q4	$0	Hold	2	–	–	﹤0.01%	705
2015 Q3	$0	Hold	2	–	–	﹤0.01%	738
2015 Q2	$2K	Buy	+2	New	+$1.64K	﹤0.01%	605

Other funds holding TTPH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Tradewinds Capital Management's TTPH Position: Q4 2016 in Review

Tradewinds Capital Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2016, closing a stake of 13 shares — an estimated $1K sold.

Tradewinds Capital Management first reported a position in TTPH in Q2 2015 and held it in 4 quarters. The position peaked at $2K in Q2 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q4 2016.

Tradewinds Capital Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Tradewinds Capital Management sold 13 Tetraphase Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1K.
Tradewinds Capital Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2015 and held it in 4 quarters.
Tradewinds Capital Management's Tetraphase Pharmaceuticals, Inc. position peaked at $2K in Q2 2015.
91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2016.

Based on Tradewinds Capital Management's 13F filing for Q4 2016, filed 3 Feb 2017.